![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
U and I Financial Corporation (QX) | USOTC:UNIF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.6965 | 5.60 | 5.70 | 0.00 | 13:52:51 |
The total number of shares purchased on October 21, 2009 was 479,800 at an average price of A$1.026 per share. Mr. Shortall has authorized his broker to purchase additional shares that will bring the total number of shares purchased this week to in excess of 500,000 shares.
Mr. Shortall said that he has elected to purchase these shares in the open market rather than participate in the recently announced private placement.
"The reason I chose to purchase these shares via the open market was to show our shareholders that I am standing by them in their belief in the Company," Mr. Shortall said.
"I could have simply participated in the private placement and obtained the shares at a discount to market and received the benefit of the same options that the institutions received, but I have instead chosen to show my allegiance to the Company and its shareholders by purchasing additional shares in the open market. I believe a direct market purchase is a truer reflection of my genuine support for our Company and my confidence in our long term prospects and world-class management team."
In considering his investment Mr. Shortall continued, "The progress the Company has made during the last two years, and our recent closing of the A$32.1 million private placement to institutional investors, provides me with the confidence to state that despite current economic conditions, I believe that Unilife has never been in a better position, operationally or financially."
About Unilife
Unilife Medical Solutions Ltd is an ISO 13485 certified company that designs, develops and supplies innovative safety medical devices. Listed on the Australian Securities Exchange (ASX: UNI) since 2002, Unilife has FDA registered manufacturing facilities in the US State of Pennsylvania and a proprietary portfolio of clinical and prefilled safety syringes designed for use within healthcare and pharmaceutical markets.
Shareholder / Analyst Enquiries: Australia Jeff Carter Phone: + 61 2 8346 6500 United States Stuart Fine Phone: + 1 908 469 1788
1 Year U and I Financial (QX) Chart |
1 Month U and I Financial (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions